Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 2 Clinical Trial to Evaluate the Efficacy in Reduction of Intraocular Pressure and Safety of PHP-201 in Patients With Normal Tension Glaucoma
Conditions
Interventions
PHP-201 0.25% ophthalmic solution
PHP-201 0.5% ophthalmic solution
+1 more
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
March 6, 2017
Primary Completion Date
May 2, 2018
Completion Date
May 2, 2018
Last Updated
October 26, 2018
NCT05902871
NCT06689696
NCT04651530
NCT06266351
NCT01864317
NCT03387306
Lead Sponsor
pH Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions